Editor

RXO to Acquire Coyote Logistics from UPS, Cementing Position as a Leader in North American Transportation

In a strategic move to bolster its presence in the North American transportation sector, RXO (NYSE: RXO) has announced its definitive agreement to acquire Coyote Logistics from UPS for $1.025 billion in cash. This acquisition is set to propel RXO to the forefront as the third-largest provider of brokered transportation in the region, significantly enhancing…

Read More

Vico Therapeutics Secures €65.8 Million in Series B Funding to Advance Groundbreaking Neurological Therapies

Vico Therapeutics, a pioneering clinical-stage genetic medicines company, has successfully closed its Series B funding round with a total investment of €65.8 million ($70.7 million). This financing round, led by Seroba and Kurma Partners, marks a significant milestone in Vico’s journey towards developing transformative therapies for severe neurological diseases. Vico Therapeutics specializes in antisense oligonucleotide…

Read More

VoltR Secures €4 Million to Revolutionize Battery Sustainability in Europe

VoltR Advances Sustainable Lithium Battery Manufacturing with €4 Million Seed Funding VoltR, a pioneering French deep-tech company specializing in sustainable lithium batteries, has successfully raised €4 million in seed funding to scale its innovative processes. The funding round, led by prominent investors including C4 Ventures, Exergon, Pays de la Loire Participations, and Anjou Amorçage, marks…

Read More

Valneva’s Breakthrough: Canada Approves World’s First Chikungunya Vaccine

Valneva SE has achieved a historic milestone with Health Canada’s approval of the world’s first chikungunya vaccine. Following its successful launch in the U.S. and pending European authorization, this decision underscores IXCHIQ®’s pivotal role in global healthcare strategy. Chikungunya, a mosquito-borne virus causing severe joint pain and fever, poses a significant public health threat with…

Read More

mika Secures €800k to Revolutionize SME Accounting with AI Innovation

In a groundbreaking move for the tech startup scene, Berlin-based mika has successfully raised €800k in pre-seed funding to bolster its mission of simplifying accounting and tax obligations for small and medium enterprises (SMEs). Led by the strategic alliance Samen Slimmer, comprising Keen Venture Partners, DFF, and Slimmer AI, this investment marks a pivotal moment…

Read More

Ethris GmbH: Leading the Charge in mRNA-Based Therapeutics with $5 Million Investment

Since its inception, Ethris GmbH has been a trailblazer in mRNA technology, revolutionizing the biotech landscape with its innovative approach to respiratory and cardiovascular diseases. Founded on a vision of harnessing messenger RNA (mRNA) for therapeutic breakthroughs, Ethris has consistently pushed boundaries, drawing attention from investors and global biotech leaders alike. Breakthroughs and Strategic Growth…

Read More

PolTREG Reports Long-Term Success in Type-1 Diabetes Treatment Study

PolTREG S.A., a pioneering biotechnology firm specializing in cellular therapies for autoimmune disorders, has announced groundbreaking findings from its long-term clinical study on PTG-007, a polyclonal Treg cell therapy for early-onset type-1 diabetes (T1D). Over a span of 7 to 12 years, pediatric patients treated with PTG-007 demonstrated sustained insulin secretion, contrasting starkly with a…

Read More

SoSoValue Secures $4.15 Million Seed Funding to Revolutionize AI-Driven Crypto Investment Research

Singapore-based fintech startup SoSoValue has announced the successful closure of a $4.15 million seed funding round, led by prominent investors including HongShan, GSR Markets, Alumni Ventures, CoinSummer Labs, and One Piece Labs. Noteworthy contributions also came from co-founders of leading Web3 and AI technology firms, alongside early backers of Ethereum and Gitcoin. Founded with a…

Read More

Marea Therapeutics Secures $190 Million to Propel Novel Cardiovascular Treatments

Marea Therapeutics has marked a significant milestone with the successful closure of a $190 million combined Series A and B financing, positioning the clinical-stage biotechnology firm to accelerate its pioneering efforts in cardiometabolic disease treatments. Led by Third Rock Ventures and supported by a consortium of leading investors including Sofinnova Investments, Forbion, and Perceptive Xontogeny…

Read More